The effects are presented as clinical events per 10,000 men, cost as Euros per man and cost-effectiveness as €/QALY. The four right most columns contrasts the clinical and costs as differences and cos
Additional file 3: Table S2. Estimated Average Health Care Utilization and Out-of-pocket Medical Spending Difference in Medical Aid Type II panel by difference-in-differences analysis. * Log Link with
The targeted population, budget impact and potential cost reduction on cervical cancer treatment, incidence and mortality cases as the results of the National Immunization Program in 2024 in Indonesia
